EQT Life Sciences closes Dementia Fund at the hard cap
· The LSP Dementia Fund has held its final close at approximately EUR 260 million, at the hard cap and above its original target fund size of EUR 100 million · Investors include the Alzheimer’s Association, the European Investment Fund, several global pharmaceutical companies, and insurance companies, amongst other · The Fund aims to bring new treatments to patients suffering from Dementia, which is one of the greatest healthcare challenges of our time · Led by Professor Philip Scheltens, one of the world’s leading experts on dementia, the LSP Dementia Fund further